BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1933140)

  • 1. The effects of naloxone on the cardiovascular and respiratory effects of centrally administered corticotrophin releasing factor in conscious rabbits.
    May CN; Whitehead CJ; Mathias CJ
    Br J Pharmacol; 1991 Jul; 103(3):1776-80. PubMed ID: 1933140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution.
    May CN; Dashwood MR; Whitehead CJ; Mathias CJ
    Br J Pharmacol; 1989 Nov; 98(3):903-13. PubMed ID: 2556206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pressor response to central administration of beta-endorphin results from a centrally mediated increase in noradrenaline release and adrenaline secretion.
    May CN; Whitehead CJ; Mathias CJ
    Br J Pharmacol; 1991 Mar; 102(3):639-44. PubMed ID: 1364832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pressor, tachycardic and behavioral excitatory responses in conscious rats following ICV administration of ACTH and CRF are blocked by naloxone pretreatment.
    Saunders WS; Thornhill JA
    Peptides; 1986; 7(4):597-601. PubMed ID: 3020526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats.
    Diamant M; Kashtanov SI; Fodor M; de Wied D
    Neuroendocrinology; 1992 Nov; 56(5):750-60. PubMed ID: 1488107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the central sites at which morphine acts to cause hypertension in conscious rabbits.
    May CN; Whitehead CJ; Dashwood MR; Mathias CJ
    Br J Pharmacol; 1989 Jul; 97(3):873-81. PubMed ID: 2569348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomic and cardiovascular effects of corticotropin-releasing factor in the spontaneously hypertensive rat.
    Brown MR; Hauger R; Fisher LA
    Brain Res; 1988 Feb; 441(1-2):33-40. PubMed ID: 2834002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system effects of corticotropin releasing factor in the dog.
    Brown MR; Fisher LA
    Brain Res; 1983 Nov; 280(1):75-9. PubMed ID: 6606481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of ketanserin on hemodynamic changes after intracerebroventricular corticotropin releasing factor administration in rats].
    Satoh K; Kushiro T; Kajiwara N
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr; 64(4):303-9. PubMed ID: 3261263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cortisol and catecholamine responses to intracerebroventricular administration of CRF to rhesus monkeys.
    Insel TR; Aloi JA; Goldstein D; Wood JH; Jimerson DC
    Life Sci; 1984 May; 34(19):1873-8. PubMed ID: 6610811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRF initiates biological actions within the brain that are observed in response to stress.
    Lenz HJ; Raedler A; Greten H; Brown MR
    Am J Physiol; 1987 Jan; 252(1 Pt 2):R34-9. PubMed ID: 3544874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mu-opioid receptor agonists on circulatory responses to simulated haemorrhage in conscious rabbits.
    Evans RG; Ludbrook J
    Br J Pharmacol; 1990 Jul; 100(3):421-6. PubMed ID: 2167731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of corticotropin-releasing factor on central respiratory activity.
    Böhmer G; Schmid K; Ramsbott M
    Eur J Pharmacol; 1990 Jul; 182(3):405-11. PubMed ID: 2226617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing factor, sauvagine, and urotensin I: effects on blood flow.
    Lenz HJ; Fisher LA; Vale WW; Brown MR
    Am J Physiol; 1985 Jul; 249(1 Pt 2):R85-90. PubMed ID: 3874558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of long-term central and peripheral administration of urocortin, corticotropin-releasing factor, and adrenocorticotropin in sheep.
    Weisinger RS; Blair-West JR; Burns P; Denton DA; Purcell B; Vale W; Rivier J; Weisinger HS; May CN
    Endocrinology; 2004 Dec; 145(12):5598-604. PubMed ID: 15319360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebroventricular injection of stresscopin-related peptide enhances cardiovascular function in conscious rats.
    Jin R; Li MZ; Bing YH; Piao RL; Li YJ; Jin QH; Qiu DL; Kannan H; Chu CP
    Regul Pept; 2013 Sep; 186():7-11. PubMed ID: 23850799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing factor and angiotensin II: comparison of CNS actions to influence neuroendocrine and cardiovascular function.
    Fisher LA; Brown MR
    Brain Res; 1984 Mar; 296(1):41-7. PubMed ID: 6608972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity.
    Diamant M; de Wied D
    Neuroendocrinology; 1993 Jun; 57(6):1071-81. PubMed ID: 8232765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ICV infusion of CRF on blood pressure and adrenal steroids in rabbits.
    Tarjan E; Ferraro T; May CN
    Neuropeptides; 1995 Jun; 28(6):325-31. PubMed ID: 7666951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiated hemodynamic responses to central versus peripheral administration of corticotropin-releasing factor in conscious rats.
    Overton JM; Fisher LA
    J Auton Nerv Syst; 1991 Jul; 35(1):43-51. PubMed ID: 1940026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.